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Abstract Seaweeds, being prolific sources of bioactive
components have garnered unprecedented interest in recent
times. The complex polysaccharides from the brown, red
and green seaweeds possess broad spectrum therapeutic
properties. Especially, the sulfated polysaccharides, viz.
fucans, carrageenans and ulvans have exhibited strong
antioxidant, antitumor, immunostimulatory, anti-inflam-
matory, pulmonary fibrosis anticoagulant/antithrombotic,
lipid lowering, antiviral, antibacterial, antiprotozoan,
hyperplasia prevention, gastrointestinal, regenerative and
nano medicine applications. Considering the immense
biomedical prospects of sulfated polysaccharides, the pro-
found and emerging functional properties published in
recent times will be discussed here with experimental
evidences. The limitations of the seaweed-derived sulfated
polysaccharides in healthcare will be summarized. Strate-
gies to maximize extraction and bioavailability will be
pondered.
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Introduction
In recent years, much attention has been focused on
polysaccharides isolated from natural sources. During the
last decade, numerous bioactive polysaccharides with
interesting functional properties have been discovered from
seaweeds (Fig. 1). Several algal species belonging to
phaeophyta, rhodophyta and chlorophyta divisions have
been recognized as crucial sources of sulfated polysac-
charides (SP). These SP constitute an important ingredient
of cell walls and get harvested by suitable extraction or
precipitation method, followed by purification, character-
ization and biological studies (Fig. 2). The biological fea-
tures of the SP reported till now are antioxidant, antitumor,
immunomodulatory, inflammation, anticoagulant, antiviral,
antiprotozoan, antibacterial, antilipemic. Currently, the
regenerative medicine and tissue engineering application of
the SP has become a hot research area. Jime´nez-Escrig
et al. (2011) have reviewed the vital role of SP from sea-
weeds in human health.
Bioactive SP extracted from seaweeds can be classified
into three types. The major fucan yielding brown seaweeds
genera are Fucus, Sargassum, Laminaria, Undaria,
Lessonia, Dictyota, Dictyopteris, Ascophyllum, Eclonia,
Canistrocarpus, Lobophota, Turbinaria, Padina, Adeno-
cystis, Sphacelaria, Cystoseira, etc. Fucan represents a
family of water soluble, SP rich in sulfated L-fucose,
extracted from extracellular matrix of these weeds (Li et al.
2008; Costa et al. 2011a). Fucoidan, the sulfated alpha-L-
fucan (term often interchangeably used with fucans) has
demonstrated a wide range of pharmacological activities.
Carrageenans are a family of linear SP, extracted from red
seaweeds, viz. Gracialaria, Gigartina, Gelidium, Lomen-
taria, Corallina, Champia, Solieria, Gyrodinium, Nema-
lion, Sphaerococcus, Boergeseniella, Sebdenia, Scinaia,
etc. This group of polysaccharides has a backbone of
alternating 3-linked b-D-galactose and 4-linked a-D-gal-
actose residues (Tuvikene et al. 2006). Three categories of
carrageenans, kappa (j), iota (i), and lambda (k) have been
identified till now based on their sulfation degree, solubility
and gelling properties (Leibbrandt et al. 2010). Ulvan is the
major water soluble, sulfated polysaccharide, extracted
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from the cell wall of green algae, viz. Ulva, Enteromorpha,
Monostroma, Caulerpa, Codium, Gayralia. Ulvans are
composed of disaccharide repetition moieties made up of
sulfated rhamnose linked to either glucuronic acid, iduronic
acid, or xylose and represent about 8–29 % of the algal dry
weight (Lahaye and Robic 2007). The above-described SP
have been illustrated in Fig. 3.
The therapeutic mechanisms of these SP vary, hence it is
yet to be studied precisely. For anticoagulation potency, the
formation of the SP/protease protein complex and the
associated non-specific polar interaction between the neg-
atively and positively charged groups in the polysaccharide
and protein is responsible for anticoagulant activity. The
anticoagulant activity is mainly attributed to thrombin
inhibition mediated by heparin cofactor II, with different
effectiveness depending on the compound. Similarly,
selectin blockade, inhibition of enzyme and complement
cascade seem to be the triggers leading to anti-inflamma-
tion. Combating viral infection has been shown by
adsorption and internalization steps (Kim et al. 2011,
2012).
Ion exchange, gel filtration, FTIR, NMR analyses are
employed to elucidate the composition and structure of SP.
Cutting edge technologies, viz. MTT assay, flow cytome-
try, western blot analysis, BCA protein assay, SDS-PAGE
and gelatin zymography has been employed for analysis of
their functional properties (Jiang and Guan 2009).
Although the use of the seaweed-derived polysaccharides
in food industry as thickening, gelling agents, and stable
excipients for control release tablets are well established,
the clinical use is still to gain ground. Manifold increase in
the published findings on this aspect in recent time is
evidence enough for the craze over this highly promising
domain. Recently, Senni et al. (2011) have reviewed the
advancement in therapeutic potential of marine polysac-
charides. However, this report was not confined to sea-
weeds and dealt only with the tissue engineering
applications. Also, Wijesekara et al. (2011) have published
Fig. 1 Seaweeds growing on the California Coast of the Pacific Ocean
Fig. 2 A flowchart depicting the sequential steps for sulfated
polysaccharide preparation and biological activity evaluation
Fig. 3 Classification of the bioactive sulfated polysaccharides
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an overview of clinically crucial SP extracted from marine
algae. Keeping with the hot trend and in an attempt to
present a new perspective, the present review summarizes
the up-to-date literature data and discusses the pharma-
ceutical potential of different SP extracted from brown, red
and green seaweeds.
Therapeutic potential of sulfated polysaccharides
Researchers across the globe are waking up to the dis-
covery that seaweed-derived bioactive products are a
storehouse of healthy attributes. Recent times have seen a
surge in interest to tap these unexploited marine sources to
develop novel therapeutics. The SP of algal origin have
exhibited miraculous biological properties. The common
seaweeds, their SP and observed bioactivity spectra have
been presented in Table 1.
Antioxidant
Souza et al. (2012) isolated a SP by aqueous extraction from
the red seaweed Gracilaria birdiae and observed that the
slimy substance exhibits moderate antioxidant properties as
measured by DPPH free-radical scavenging effect. Veena
et al. (2007) evaluated the efficacy of fucoidan from edible
seaweed Fucus vesiculosus in Wistar rats (5 mg/kg body wt.).
Advocation of the SP enhanced the antioxidant status,
thereby preventing membrane injury and averting stone for-
mation. Barahona et al. (2011) evaluated the antioxidant
capacity of sulfated galactans from red seaweed Gigartina
skottsbergii and Schizymenia binderi, commercial carrag-
eenans, and fucoidan from brown seaweed Lessonia vadosa
by the oxygen radical absorbance capacity (ORAC) method.
Fucoidan from L. vadosa and the sulfated galactan from S.
binderi exhibited the highest antioxidant capacity. The anti-
oxidant capacity was also evaluated by ABTS and hydroxyl
radical scavenging assays. Corallina sertularioide, Dictyota
cervicornis, Sargassum filipendula and Dictyopteris delica-
tula were studied and found to have SP having immense
antioxidant potential in the form of total antioxidant, reducing
power and ferrous ion chelating activities (Costa et al. 2010).
Two SP fractions rich in galactose and xylose from Corallina
officinalis demonstrated considerable antioxidant properties
(Yang et al. 2011). Hu et al. (2010) isolated two sulfated
rhamnose-rich polysaccharide fractions from Undaria pin-
natifida and evaluated their antioxidant abilities in vitro. It
was revealed that the SP possessed strong antioxidant prop-
erties. Ye et al. (2008) evaluated the antioxidant activities of
SP from Sargassum pallidum by DPPH (2,2-diphenyl-1-
picrylhydrazyl)-free-radical scavenging assay and reported
activity, though low at the tested concentration. Camara et al.
(2011) extracted heterofucans from Canistrocarpus
cervicornis by proteolytic digestion followed by sequential
acetone precipitation. The SP exhibited total antioxidant
capacity, low hydroxyl radical scavenging activity, good
superoxide radical scavenging efficiency and excellent fer-
rous chelating ability. Devaki et al. (2009) studied the liver
mitochondrial and microsomal fraction from rats to evaluate
the antioxidative effect of oral gavaging with Ulva lactuca
polysaccharide extract (200 mg/kg body weight, daily for
21 days). Electron microscopy of rat liver tissue intoxicated
with D-galactosamine revealed the swelling and loss of
mitochondrial cristae. However, the rats pre-treated with the
SP overcame the D-galactosamine challenge without signifi-
cant abnormality of TCA, microsomal enzymes and mito-
chondria structural aberrations. These results suggested that
the SP play crucial role in stabilizing the functional status of
mitochondrial and microsomal membrane by prevention of
the oxidative stress induced by D-galactosamine. Fucoidan
was extracted from Laminaria japonica through anion-
exchange column chromatography and their antioxidant
activities were investigated. Superoxide and hydroxyl radical
scavenging activity, chelating ability and reducing power
analysis showed that all fractions possessed considerable
antioxidant activity (Wang et al. 2008). Gao et al. (2011)
investigated the effects of fucoidan on improving learning
and memory impairment in rats induced by infusion of beta-
amyloid peptide, Ab (1–40) and its possible mechanisms. The
results indicated that fucoidan could ameliorate Ab-induced
cognitive disorders in neural maladies like Alzheimer’s. The
mechanisms appeared to regulate the cholinergic system
(increasing the activity of choline acetyl transferase), reduce
the oxidative stress (reduced malondialdehyde content in
hippocampal tissue of brain) and inhibit the cell apoptosis
(increase of Bcl-2/Bax ratio and a decrease of caspase-3
activity). Hong et al. (2011) investigated the protective
effect of fucoidan on dimethylnitrosamine-induced liver
fibrogenesis in rats. When administered (100 mg/kg, 3 times
per week), fucoidan improved liver fibrosis by inhibiting the
expression of transforming growth factor beta 1 [TGF-b
(1)]/Smad3 and the tissue inhibitor of metalloproteinase 1
(TIMP-1), and increasing the expression of metallopro-
teinase-9 (MMP-9). Fucoidan also significantly decreased
the accumulation of the extracellular matrix and collagen,
confirming its anti-fibrotic effect. Costa et al. (2011b)
obtained five sulfated heterofucans from S. filipendula by
proteolytic digestion followed by sequential acetone pre-
cipitation, which displayed considerable antioxidant poten-
tial. Magalhaes et al. (2011) obtained six families of SP
from seaweed D. delicatula employing above-mentioned
protocols, followed by molecular sieving on Sephadex
G-100. Some fractions of the heterofucans showed high
ferrous ion chelating activity and some fractions showed
reasonable reducing power, about 53.2 % of the activity of
vitamin C. These results clearly indicate the beneficial
3 Biotech (2012) 2:171–185 173
123
Table 1 The studied seaweeds, their bioactive sulfated polysaccharides and therapeutic properties
Biological properties Seaweed Sulfated polysaccharide References
Antioxidant Gracilaria birdiae (red) Fucoidan Souza et al. (2012)
Fucus vesiculosus (brown) Galactan Veena et al. (2007)
Gigartina skottsbergii (red) Carrageenan Barahona et al. (2011)
Schizymenia binderi (red) Rhamnan Magalhaes et al. (2011)
Lessonia vadosa (brown) Costa et al. (2011a, b)
Dictyopteris delicatula (brown) Wang et al. (2008)
Sargassum filipendula (brown) Devaki et al. (2009)
Laminaria japonica (brown) Camara et al. (2011)
Ulva lactuca (green) Hu et al. (2010)
Canistrocarpus cervicornis (brown) Yang et al. (2011)






Antitumor Saccharina japonica (brown) Galactofucan Vishchuk et al. (2011)
Undaria pinnatifida (brown) Mannoglucuronofucan Costa et al. (2010)
Sargassum filipendula (brown) Charles et al. (2007)
Dictyopteris delicatula (brown) Ye et al. (2008)
Caulerpa prolifera (green) Croci et al. (2011)
Dictyota menstrualis (brown) Ermakova et al. (2011)
Monostroma nitidum (green) Costa et al. (2011a, b)
Sargassum pallidum (brown) Magalhaes et al. (2011)
Laminaria saccharina (brown) Jin et al. (2010)
Ecklonia cava (brown) Lins et al. (2009)
Sargassum hornery (brown) Foley et al. (2011)






Immunostimulatory Enteromorpha prolifera (green) Fucoidan Kim et al. (2011, 2012)
Champia feldmannii (red) j-carrageenan Lins et al. (2009)
Fucus vesiculosus (brown) Oligosaccharides Kawashima et al. (2011)
Kappaphycus striatum (red) Kima and Joo (2008)
Antiinflammation and
antinociceptive
Solieria filiformis (red) Galactan de Arau´jo et al. (2011)
Gelidium crinale (red) Mannoglucuronofucans Farias et al. (2011)
Sargassum hemiphyllum (brown) j-carrageenan de Sousa et al. (2011a)
Gracilaria cornea (red) Oligosaccharides Hwang et al. (2011)
Gracilaria birdiae (red) Coura et al. (2011)
Laminaria saccharina (brown) Croci et al. (2011)
Lobophora variegate (brown) Medeiros et al. (2008)
Turbinaria ornata (brown) Ananthi et al. (2009)
Padina gymnospora (brown) Marques et al. (2012)
Jiang and Guan (2009)
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effects of SP from seaweeds in antioxidant status of
consumers.
Antitumor
Vishchuk et al. (2011) isolated fucoidans from brown
seaweeds Saccharina japonica and U. pinnatifida and tes-
ted their antitumor activity against human breast cancer
T-47D and melanoma SK-MEL-28 cell lines. The highly
branched partially acetylated sulfated galactofucan, built
up of (1 ? 3)-a-L-fucose residues from S. japonica and U.
pinnatifida distinctly inhibited proliferation and colony
formation in both breast cancer and melanoma cell lines in
a dose-dependent manner. These results indicated that the
fucoidan from the studied seaweeds may be a potential
approach toward cancer treatment. After 72-h incubation of
Table 1 continued
Biological properties Seaweed Sulfated polysaccharide References
Anticoagulation and
antithrombosis)
Ecklonia cava (brown) Arabinogalactans Wijesinghe et al. (2011)
Dictyota cervicornis (brown) Rhamnan Costa et al. (2010)
Caulerpa cupresoides (green) Galactan Ciancia et al. (2007)
Codium fragile (green) Li et al. (2011)
Codium vermilara (green) Mao et al. (2008)
Monostroma latissimum (green) Camara et al. (2011)
Monostroma nitidum (green) Albuquerque et al. (2004)
Canistrocarpus cervicornis (brown) Pushpamali et al. (2008)
Dictyota menstrualis (brown) Croci et al. (2011)
Lomentaria catenata (red)
Laminaria saccharina (brown)
Lipid lowering Ulva lactuca (green) Fucoidan Kim et al. (2010)
Sargassum polycystum (brown) Sathivel et al. (2008)
Sargassum wightii (brown) Raghavendran et al. (2005)
Laminaria japonica (brown) Huang et al. (2010)
Antiviral (Influenza, herpes, HIV) Gyrodinium impudium (red) Galactan Ghosh et al. (2009)
Nemalion helminthoides (red) Mannans Kim et al. (2011, 2012)
Gayralia oxysperma (green) Heterorhamnan Recalde et al. (2009)
Sphaerococcus coronopifolius (red) Xylomannan sulfate Cassolato et al. (2008)
Boergeseniella thuyoides (red) Xylogalactofucan Bouhlal et al. (2011)
Sebdenia polydactyla (red) Xylomannan Bandyopadhyay et al. (2011)
Sphacelaria indica (brown) Mandal et al. (2007)
Cystoseira indica (brown)
Grateloupia indica (red) Chattopadhyay et al. (2007)
Laminaria angustata (brown) Trinchero et al. (2009)





Kappaphycus alvarezii (red) Fucoidan Kumaran et al. (2010)
Padina boergessenii (brown) Maruyama et al. (2007)
Undaria pinnatifida (brown) Chen et al. (2009)
Prevent hyperplasia Brown seaweeds Fucoidan Hlawaty et al. (2011)
Freguin-Bouilland et al. (2007)
Cause gastrointestinal contraction Halymenia floresia (red) Galactan Grac¸a et al. (2011)
Cladosiphon okamuranus Tokida (brown) Fucoidan Matsumoto et al. (2004)
Regenerative and nano medicine Brown seaweeds Fucoidan Sezer et al. (2008)
Ulva rigida (green) Ulvan Murakami et al. (2010)
Nakamura et al. (2008)
Fukuta and Nakamura (2008)
Toskas et al. 2011)
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HeLa cell with SP (0.01–2 mg/ml), the proliferation was
inhibited between 33.0 and 67.5 % by S. filipendula; 31.4
and 65.7 % by D. delicatula; 36.3 and 58.4 % by Caulerpa
prolifera, and 40.2 and 61.0 % by Dictyota menstrualis.
Costa et al. (2010) inferred that the antiproliferative effi-
cacy of SP positively correlated with the sulfate content. In
Sprague–Dawley rats fed with Monostroma nitidum diet,
significant increase in UGT1A1 and UGT1A6 mRNA
levels was found, indicating potential application in che-
moprevention medicine (Charles et al. 2007). Ye et al.
(2008) evaluated the antitumor activities of SP from S.
pallidum by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide] assay, which showed a signifi-
cantly high antitumor activity against the human
hepatocellular carcinoma (HepG2), human lung adenocar-
cinoma epithelial (A549) and human gastric carcinoma
(MGC-803) cells. Croci et al. (2011) explored the possible
antitumor activities of SP from the brown seaweed Lami-
naria saccharina. The incorporation of the parent SP and
the sulfated fucans into Matrigel plugs containing mela-
noma cells induced a significant reduction in hemoglobin
content as well as the frequency of tumor-associated blood
vessels. Also, these two SP administrations resulted in a
significant reduction of tumor growth when inoculated into
mice. The sulfated fucan fraction markedly inhibited breast
cancer cell adhesion to human platelet-coated surfaces.
Ermakova et al. (2011) showed that fucoidans from brown
algae Eclonia cava, Sargassum hornery and Costaria
costata play an inhibitory role in colony formation in
human melanoma and colon cancer cells. Costa et al.
(2011b) observed antiproliferative activity of fucan from S.
filipendula against HeLa cells by MTT test. The heter-
ofucan was extracted from the brown seaweed by proteo-
lytic digestion followed by sequential acetone
precipitation. This SP showed antiproliferative activity on
Hela cells and induced apoptosis by mitochondrial release
of apoptosis-inducing factor (AIF) into cytosol. In addition,
it decreased the expression of anti-apoptotic protein Bcl-2
and increased expression of apoptogenic protein Bax.
Magalhaes et al. (2011) obtained six families of SP from
seaweed D. delicatula by proteolytic digestion, followed
by acetone fractionation and molecular sieving on Sepha-
dex G-100. A fraction of the heterofucan showed high
antiproliferative activity inhibiting almost 100 % of HeLa
cell proliferation. Jin et al. (2010) investigated the effects
of fucoidan on the apoptosis of human promyeloid leuke-
mic cells and fucoidan-mediated signaling pathways. Fu-
coidan induced apoptosis of human promyelocytic
leukemia (HL-60), human promyelocytic (NB4) and THP-
1 (human acute monocytic leukemia) cell line. Fucoidan
treatment of HL-60 cells induced activation of caspases 8,
9, and 3, the cleavage of Bid, and altered mitochondrial
membrane permeability. Buthionine-[R,S]-sulfoximine
rendered HL-60 cells more sensitive to fucoidan. It was
concluded that the activation of MEKK1, MEK1, ERK1/2
and JNK, depletion of glutathione and production of NO
are important mediators in fucoidan-induced apoptosis of
human leukemic cells. Lins et al. (2009) investigated the in
vitro and in vivo antitumor properties of a SP isolated from
the seaweed C. feldmannii. The SP did not show any sig-
nificant in vitro cytotoxicity at the experimental dose, but
showed in vivo antitumor effect. The inhibition rates of
sarcoma 180 tumor development were 48.62 and 48.16 %
at the doses of 10 and 25 mg/kg, respectively. It also
increased the response elicited by anti-cancer drug, 5-flu-
orouracil (5-FU) from 48.66 to 68.32 %. Though liver and
kidney were moderately affected, the enzymatic activity of
alanine aminotransferase or urea/creatinine levels was not
disturbed. Leucopenia associated with 5-fluorouracil
treatment was prevented when the chemotherapeutic was
administered along with SP. An unfractionated fucoidan
was extracted from the brown alga Ascophyllum nodosum
and its effect on the apoptosis of human HCT116 colon
carcinoma cells was studied and the signaling pathways
involved were investigated. Fucoidan decreased cell via-
bility and induced apoptosis of the carcinoma cells, through
activation of caspases 9 and 3 and the cleavage of PARP
(Foley et al. 2011). Haneji et al. (2005) examined the effect
of fucoidan from the brown seaweed Cladosiphon oka-
muranus Tokida against an incurable form of cancer, the
adult T-cell leukemia (ATL). It was observed that fucoidan
inhibited the growth of peripheral blood mononuclear cells
of ATL patients and caused apoptosis of HTLV-1-infected
T-cell lines through a cascade of down regulations. In vivo
treatment of the cancer transplanted in mice also showed
partial inhibition of the tumors. Now that, cancer has
assumed an epidemic proportion and the treatment scenario
is still bleak, the SP from the marine weeds hold the
promise for novel anticancer formulae.
Immunostimulatory
Water-soluble SP extracted from Enteromorpha prolifera
and fractionated using ion-exchange chromatography was
investigated to determine their in vitro and in vivo
immunomodulatory activities. Some fractions stimulated a
macrophage cell line Raw 264.7 inducing considerable
nitric oxide (NO) and various cytokine production via up-
regulated mRNA expression. The in vivo experiment
results showed increase in IFN-c and IL-2 secretions,
suggesting that the SP is a strong immunostimulator. It is
implied that the SP can activate T cells by up-regulating
Th-1 response (Kim et al. 2011). Lins et al. (2009) dem-
onstrated that SP extracted from C. feldmannii is an
immunomodulatory agent, evident from the increase in the
production of specific antibodies. Kawashima et al. (2011)
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demonstrated that fucoidan enhances the probiotic effects
of lactic acid bacteria on immune functions. In vitro test
results showed that fucoidan amplified interferon (IFN)-c
production mediated by IL-12 production from Peyer’s
patch and spleen cells in response to a strain of LAB,
Tetragenococcus halophilus KK221. In vivo study showed
that Th1/Th2 immunobalance was significantly improved
by oral administration of both fucoidan and KK221 to
ovalbumin-immunized mice. Kima and Joo (2008)
observed that fucoidan from F. vesiculosus shows immu-
nostimulating and maturing effects on dendritic cells (DCs)
via a pathway involving nuclear factor-jB (NF-jB). j-
Carrageenan oligosaccharides from red algae Kappaphycus
striatum have immunomodulation effects on S180 tumor-
bearing mice. The sulfated derivative (200 lg/g/day)
showed an increase in natural killer cells (NK cells) up to
76.1 %. It suggested that chemical modification (especially
sulfation) of carrageenan oligosaccharides can enhance
their antitumor effect and boost their antitumor immunity.
Yuan et al. (2011) reported not only the capacity of SP to
elicit cellular immunity but also the importance of chem-
ical modification of the parent polysaccharide.
Anti-inflammation/antinociception/inhibition
of pulmonary fibrosis
de Arau´jo et al. (2011) studied the antiinflammatory and
antinociception (less sensitivity to painful stimulus) prop-
erties of seaweed Solieria filiformis in vivo. Male Swiss
mice pre-treated with the SP, on receiving an injection of
0.8 % acetic acid, 1 % formalin or 30 min prior to a
thermal stimulus, showed significantly reduced number of
writhes. It showed antinociceptive action through a
peripheral mechanism; however, did not show any signif-
icant anti-inflammatory effect. The SP from the brown
seaweed Spatoglossum schroederi was assayed for the
antinociceptive effect on Swiss mice. The SP purified by
anion-exchange chromatography inhibited both phases of
the formalin test. In the first phase the maximum 45 %
reduction in paw licking was observed. This inhibitory
effect suggested a mixed mechanism similar to morphine,
which was not confirmed in the hot-plate test. It was con-
cluded that the pronounced antinociceptive effect of SP
could be developed as a new source of analgesic drugs
(Farias et al. 2011). The SP galactan extracted from the red
marine alga Gelidium crinale was purified by ion-exchange
chromatography and tested by intravenous route in rodent
experimental models of inflammation and nociception. The
anti-inflammatory activity was evaluated in the model of
rat paw edema induced by different inflammatory stimuli.
Antinociceptive effect was assessed in models of noci-
ception/hyperalgesia elicited by chemical (formalin test),
thermal (hot plate), and mechanical (von Frey) stimuli in
mice. It was observed that SP inhibited the time course of
dextran-induced paw edema and showed a maximal effect
at 1 mg/kg (42 %). At the highest dose, the SP also
inhibited the paw edema induced by histamine (49 %) and
phospholipase A(2) (44 %). The galactan inhibited both
neurogenic and inflammatory phases of the formalin test
and the treatment was well tolerated by the test animals (de
Sousa et al. 2011a). Hwang et al. (2011) explored SP from
brown seaweed Sargassum hemiphyllum for possible anti-
inflammatory effect. The SP was administered against the
mouse macrophage cell line (RAW 264.7) activated by
lipopolysaccharide (LPS). The secretion profiles of pro-
inflammatory cytokines, including IL-1b, IL-6, TNF-a, and
NO, were found significantly to be reduced in 1–5 mg/ml
dose ranges of SP treatments. RT-PCR analysis suggested
that the SP inhibits the LPS-triggered mRNA expressions
of IL-b, iNOS and COX-2 in a dose-dependent manner. It
was concluded that the anti-inflammatory properties of SP
may be attributed to the down-regulation of NF-jB in
nucleus. Coura et al. (2011) evaluated the effects of SP
from the red seaweed Gracilaria cornea in nociceptive and
inflammatory mice models. At all tested doses, the SP
significantly reduced nociceptive responses, as measured
by the number of writhes. In a formalin test, the SP sig-
nificantly reduced licking time in both phases of the test at
a dose of 27 mg/kg. In a hot-plate test, the antinociceptive
effect was observed only in animals treated with 27 mg/kg
of SP, suggesting that the analgesic effect occurs through a
central action mechanism at the highest dose. The lower
doses of SP (3 and 9 mg/kg) caused only a slight reduction
in neutrophil migration in the rat peritoneal cavity but
significantly inhibited paw edema induced by carrageenan,
especially at 3 h after treatment. Reduction in edema was
confirmed by myeloperoxidase activity in the affected paw
tissue. After 14 consecutive days of intraperitoneal
administration of the SP (9 mg/kg), the biochemical,
hematological and histopathological evaluations of the
internal organs are performed and no systemic damage was
found. de Sousa et al. (2011b) investigated the involvement
of the hemoxygenase-1 (HO-1) pathway in the anti-
inflammatory action of a SP from the red seaweed G.
birdiae. The SP was administered at various concentrations
to Wistar rats and observed that at 10 mg/kg concentration,
it exerted an anti-inflammatory effect. A remarkable
decrease in leukocytes in the peritoneal cavity was also
observed. The SP also reduced the paw edema induced by
carrageenan and inhibited the paw edema induced by
dextran in the first half-hour. The O-sulfated mann-
oglucuronofucans and sulfated fucan fractions from the
brown seaweed L. saccharina were evaluated for possible
treatment of inflammation in vivo. Both types of SP
exhibited inhibition of leukocyte rush into the sites of
inflammation in the murine models (Croci et al. 2011).
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Medeiros et al. (2008) extracted a sulfated heterofucan
from the brown seaweed Lobophora variegata by proteo-
lytic digestion, followed by acetone fractionation, molec-
ular sieving, and ion-exchange chromatography. The
fucoidan revealed that it inhibits leukocyte migration to the
inflammation site. Ear swelling caused by croton oil was
also inhibited when sulfated polysaccharides from F. ves-
iculosus and L. variegata were used. Ananthi et al. (2009)
investigated the anti-inflammatory effect of crude SP from
brown alga Turbinaria ornata against carrageenan-induced
paw edema in rats and vascular permeability in mice. Oral
administration of SP reduced the paw edema and showed
inhibitory effect on vascular permeability considerably, in
a dose-dependent manner. SP extracted from brown algae
Padina gymnospora showed efficacy in reducing leukocyte
influx into the peritoneal cavity in mice at 10 mg/kg body
weight, causing a decrease of 60 %, without any cytotox-
icity (Marques et al. 2012). Idiopathic pulmonary fibrosis is
a pathological condition characterized by accumulation of
excess fibroblasts, deposition of collagen and inflammation
in lungs. The pro-fibrogenic cytokine transforming growth
factor-beta 1 (TGF-beta1) has attracted much attention for
its potential role in the etiology of this serious lung injury.
MS80, a new kind of sulfated oligosaccharide extracted
from seaweed, inhibits TGF-beta1-induced pulmonary
fibrosis in vitro and bleomycin-induced pulmonary fibrosis
in vivo. The oligosaccharide competitively inhibited hep-
arin/HS-TGF-beta1 interaction through its high binding
affinity for TGF-beta1, also arrested human embryo pul-
monary fibroblast (HEPF) cell proliferation and collagen
deposition. MS80 proved to be a potent suppressor of
bleomycin-induced rat pulmonary fibrosis in vivo (Jiang
and Guan 2009). Du et al. (2010) reported that efficacy of
MS80 lies in targeting the CD40 signal pathway by
blocking RIP2. The precise mechanism of functionality is
not clear; nevertheless, the sulfated polysaccharides studied
above promise therapeutic potential in inflammatory
disorders.
Anticoagulation
Batteries of assays for assessment of anticoagulation
properties of SP from seaweeds have been conducted in
recent times. Tests ranging from activated partial throm-
boplastin time (APTT), thrombin time (TT), prothrombin
time (PT), antithrombin to anticoagulation factor Xa
activities have been performed and compared with heparin.
Wijesinghe et al. (2011) purified a SP from brown seaweed
Ecklonia cava and investigated its anticoagulant activity in
vitro and in vivo. It extended the coagulation time in Wi-
star rats in a dose- and time-dependent manner. Costa et al.
(2010) evaluated in vitro anticoagulant activities of marine
algae SP by APTT test. D. cervicornis SP prolonged the
coagulation time, only 1.4-fold lesser than Clexane, a low
molecular weight commercial heparin. In the prothrombin
time (PT) test, which evaluates the extrinsic coagulation
pathway, Caulerpa cupresoides showed aggression. Codi-
um fragile and Codium vermilara water-soluble sulfated
arabinogalactans prevented coagulation, but they induced
platelet aggregation. It was observed that anticoagulant
activity was higher in SP samples with higher sulfate
content. In this regard, C. vermilara proved to be superior
with a higher degree of sulfation and arabinose content
(Ciancia et al. 2007). The hot water extract of green alga
Monostroma latissimum gives a sulfated rhamnan poly-
saccharide with an anticoagulant activity. The anticoagu-
lant activity as evaluated by assays of the APTT and
thrombin time promises that it can be a potential source of
anticoagulant (Li et al. 2011). Mao et al. (2008) isolated
two sulfated, rhamnose-containing polysaccharides from
marine green algae M. nitidum and evaluated their anti-
coagulant activities. The results showed that both the SP
possess high anticoagulant activities, and were potent
thrombin inhibitors mediated by heparin cofactor II. They
also hastened thrombin and coagulation factor Xa inhibi-
tion by potentiating antithrombin III. Camara et al. (2011)
extracted sulfated heterofucans from C. cervicornis which
prolonged APTT. Four sulfated polysaccharides doubled
APTT with only 0.1 mg/ml of plasma, only 1.25-fold less
than Clexane. Albuquerque et al. (2004) extracted heter-
ofucans from the brown seaweed D. menstrualis by pro-
teolytic digestion, followed by sequential acetone
precipitation. The anticoagulant activities of these heter-
ofucans were determined by APTT test. A fucan fraction
(20 g/ml) demonstrated significant anticoagulant activity,
about 4.88-fold lesser than Clexane (4.1 g/ml). Pushpa-
mali et al. (2008) isolated a highly sulfated (21.76 %),
100–500 kDa molecular weight galactan anticoagulant
from microbial-fermented freeze-dried red algae Lomen-
taria catenata. It demonstrated that the anticoagulant
compound showed better efficacy than heparin and pro-
longed activity toward APTT and PT assays. Croci et al.
(2011) studied that the SP from the brown seaweed L.
saccharina shows promising activity on thrombosis.
Ferna´ndez et al. (2012) studied the anticoagulation efficacy
of sulfated b-D-mannan extracted from green seaweed C.
vermilara and reported that higher sulfate content leads to
more pronounced effect. Fucoidan has been proposed as a
potential substitute of the anticoagulant heparin, with
added merits. Unlike mammalian mucosa-derived heparin,
fucoidan is extracted from plants, so less likely to contain
infectious agents, such as viruses or prions (Boisson-Vidal
et al. 1995). The current findings promise a host of possible
candidates for natural anticoagulant preparation.
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Lipid lowering
Fucoidan has been reported to affect the development of
adipocytes. To elucidate the role of fucoidan in adipogen-
esis, its inhibitory effect on adipocyte differentiation via
mitogen-activated protein kinase (MAPK) signaling path-
way in 3T3-L1 preadipocytes was studied. Fucoidan treat-
ment inhibited the adipocyte differentiation, evidenced by
decreased lipid accumulation and down-regulation of adi-
pocyte markers. Also, it inhibited the expression of adipo-
genic transcription factors, a (C/EBPa), c (PPARc) and
AP2, crucial for adipocyte development (Kim et al. 2010).
Sathivel et al. (2008) evaluated the anti-peroxidative and
anti-hyperlipidemic property of U. lactuca polysaccharide
extract against D-galactosamine (500 mg/kg body weight)-
induced anomaly in rat. D-Galactosamine-intoxicated rats
showed significant liver damage with acute aberration in
serum lipid profile, hepatic protein thiols, deposits of lipid
droplets and abnormal appearance of mitochondria. Rats
pretreated with ulvan (30 mg/kg body weight/day/for
21 days) showed a significant inhibition against abnormal-
ity induced by D-galactosamine. The effect of Sargassum
polycystum crude SP extract on lipid metabolism was
examined against acetaminophen-induced hyperlipidemia
in experimental rats. The prior oral administration of S.
polycystum (200 mg/kg body wt./day for a period of
15 days) crude SP extract showed considerable prevention
in the severe disturbances of lipid profile and metabolizing
enzymes (serum lecithin cholesterol acyl transferase and
hepatic triglyceride lipase) triggered by acetaminophen.
Liver histology also supported their protective nature
against fatty changes induced during acetaminophen
intoxication (Raghavendran et al. 2005). Josephine et al.
(2007) studied the possible capacity of SP in normalizing
hyperlipidemia induced by the immunosuppressant drug
cyclosporine A (25 mg/kg body weight, orally for 21 days)
in Wistar rat kidney. As a side effect of the drug, lipid
profile showed fluctuation resulting in nephrotoxicity
manifested by the enhanced urinary excretion of urea, uric
acid and creatinine. The SP-treated groups (5 mg/kg body
weight, subcutaneously) showed a normalized lipid profile
and lipid metabolizing enzymes. Moreover, this group of
rats showed a normal concentration of urinary constituents.
Huang et al. (2010) investigated the effect of fucoidan from
L. japonica on hyperlipidemic rats. The SP reduced the
concentration of serum total cholesterol, triglyceride and
low-density lipoprotein cholesterol and increased the con-
centration of high-density lipoprotein cholesterol of the
studied rats. The activities of lipoprotein lipase, hepatic
lipoprotein and lecithin cholesterol acyltransferase were
also enhanced. Above findings corroborate that the SP from
seaweeds are ideal option for effective abatement of the
lipid abnormalities.
Antiviral
Many viruses display affinity for cell surface heparan sul-
fate proteoglycans playing crucial role in virus entry. This
raises the possibility of the application of SP in antiviral
therapy (Ghosh et al. 2009). Kim et al. (2012) purified a
SP, p-KG03, from the red marine microalga, Gyrodinium
impudium. The galactan conjugated to uronic acid and
sulfated groups had showed inhibition of encephalomyo-
carditis virus. The inhibitory activity of the SP against
influenza virus was examined. The results of a cytopathic
effect reduction assay using MDCK cells demonstrated that
p-KG03 exhibited the 50 % effective concentration (EC50)
values of 0.19–0.48 lg/ml against influenza type A virus
infection. The antiviral activity of p-KG03 was deduced
to be directly associated with its interaction with viral
particles, interfering with its adsorption and internaliza-
tion into host cell. It was expected to be a candidate for
antiviral drug development. The soluble fractions of a
sulfated, (1 ? 3)-linked a-D-mannans obtained by hot
water extraction from Nemalion helminthoides showed
appreciable antiherpetic activity (Recalde et al. 2009). A
homogeneous branched sulfated heterorhamnan was
obtained by aqueous extraction, followed by ultrafiltration
from the green seaweed Gayralia oxysperma which exerted
high specific activity against herpes simplex virus (HSV-1)
(Cassolato et al. 2008). Treatment of human immunodefi-
ciency virus type 1 (HIV-1), the dreaded etiological agent
of AIDS poses tough challenges. The limitations encoun-
tered in therapeutic strategy are toxicity, resistance and
high costs. Water-soluble sulfated galactans isolated from
two red algae Sphaerococcus coronopifolius (Gigartinales,
Sphaerococcaceae) and Boergeseniella thuyoides (Ceram-
iales, Rhodomelaceae) inhibited in vitro replication of the
human immunodeficiency virus (HIV) at 12.5 lg/ml. In
addition, the studied polysaccharides were capable of
inhibiting the in vitro replication of HSV-1 on Vero cells.
The adsorption step of HSV-1 to the host cell seemed to be
the specific target for the SP action. While for HIV-1, these
results suggest a direct inhibitory effect on HIV-1 repli-
cation by controlling the appearance of the new generations
of virus and potential virucidal effect (Bouhlal et al. 2011).
Ghosh et al. (2009) studied that xylomannan sulfate and its
sulfated derivatives purified from Sebdenia polydactyla
showed strong activity against HSV-1. The IC50 values
were in the range 0.35–2.8 lg/ml and they did not exert
cytotoxicity at concentrations up to 1,000 lg/ml. Many
xylogalactofucan- and alginic acid-containing fractions
from marine alga Sphacelaria indica showed antiherpetic
activity. The IC50 values of their chemically sulfated
derivatives against HSV-1 were in the range of 0.6–10 lg/
ml and they lacked cytotoxicity at concentrations up to
200 lg/ml (Bandyopadhyay et al. 2011). Sulfated fucan-
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containing fractions isolated from the brown seaweed
Cystoseira indica showed potent antiviral activity against
HSV-1 and 2 HSV-2 without cytotoxicity for Vero cell
cultures. Chemical, chromatographic and spectroscopic
methods showed that the anti-herpetic activity of the SP is
by inhibition of the virus adsorption (Mandal et al. 2007).
Chattopadhyay et al. (2007) analyzed the SP fractions
isolated from crude water extract of Grateloupia indica and
showed their potent anti-HSV activity. The SP, xyloga-
lactofucan fractions extracted from Laminaria angustata,
after addition of sulfate groups showed enhanced capability
to inhibit HSV-1. The IC50 values of these fractions
against HSV-1 were in the range of 0.2–25 lg/ml and they
lacked cytotoxicity at concentrations up to 1,000 lg/ml
(Saha et al. 2012). SP fractions from brown seaweed Ad-
enocystis utricularis were analyzed for their in vitro anti-
HIV-1 activity. Two of the five studied fractions showed
potent anti-HIV-1 activity both against wild type and drug-
resistant HIV-1 strains, mediated by blockade of early
events of viral replication (Trinchero et al. 2009). The
antiviral activity was dependent on the sulfate contents of
the polysaccharides. Kazłowski et al. (2012) conducted
both in vitro and in vivo studies on Japanese encephalitis
virus prevention property of novel SP from Gracilaria sp.
and M. nitidum. During in vitro studies performed by MTT
or plaque assays, low-degree-polymerization SP showed a
remarkably high positive effect on survivability in JEV-
infected C3H/HeN mice. The in vivo antiviral activity was
assumed to be a resultant of better absorption of low-DP SP
than undigested PS. The results support the feasibility of
antiviral drug development from various SP and their
derivatives.
Antibacterial and antiprotozoan
Kumaran et al. (2010) studied that SP extracted from red
alga Kappaphycus alvarezii and brown alga Padina boer-
gessenii exert promising inhibitory response against anti-
microbial-resistant Escherichia coli strains and, in
particular, the inhibitory response of ampicillin-resistant E.
coli, isolated from local fish markets and seafood pro-
cessing plants. Maruyama et al. (2007) investigated the
effects of fucoidan isolated from the sporophyll of U.
pinnatifida on the Cryptosporidium parvum adhesion to the
cultured human intestinal cells and its infection in neonatal
mice. The C. parvum adhesion to human intestinal 407
cells was significantly suppressed by a low dose (1 mg/ml)
of fucoidan (1 lg/ml). The results of the in vivo experi-
ments revealed that C. parvum oocysts in the fucoidan-
treated mice was reduced to nearly one-fifth of the oocysts
number treated with phosphate buffered saline. It was
concluded that fucoidan might inhibit cryptosporidiosis
through the direct binding of fucoidan to the C. parvum-
derived functional mediators in the intestinal epithelial
cells in neonatal mice. Chen et al. (2009) investigated the
inhibitory effects of fucoidan from the edible brown sea-
weed U. pinnatifida, on the growth of Plasmodium para-
sites. The antimalarial activity of fucoidan was assessed
against the cultured Plasmodium falciparum parasites in
vitro and on Plasmodium berghei-infected mice in vivo.
Fucoidan significantly inhibited the invasion of erythro-
cytes by P. falciparum merozoites. Its 50 % inhibition
concentration was similar to those for the chloroquine-
sensitive P. falciparum 3D7 strain and the chloroquine-
resistant K1 strain. Four-day suppressive testing in
P. berghei-infected mice with fucoidan resulted in a 37 %
suppressive effect versus the control group and a delay in
death associated with anemia.
Prevent hyperplasia
Hlawaty et al. (2011) investigated the therapeutic potential
of low molecular weight fucoidan on vascular smooth
muscle cell and human vascular endothelial cell prolifer-
ation and migration in vitro and in vivo. Sprague–Dawley
rats with induced thoracic aorta injury were treated with SP
(5 mg/kg/day) for 14 days. Results showed that SP pre-
vented intimal hyperplasia in rat thoracic aorta. In situ
zymography showed that the activity of matrix metallo-
proteinase (MMP)-2 in the neo-intima is significantly
reduced. Fucoidans have been shown to mobilize bone
marrow-derived progenitor cells via stimulation of stromal-
derived factor (SDF)-1 release. Mobilized progenitor cells
have been suggested to repair intimal lesions after immune-
mediated endothelial injury and thus prevent intimal pro-
liferation. Freguin-Bouilland et al. (2007) evaluated the
therapeutic effect of these SP, in Brown Norway and Lewis
rat aortic allograft model of transplant arteriosclerosis. The
recipient rats were treated with SP (5 mg/kg/day) for
30 days. In contrast to untreated aortic allografts, the SP-
treated allografts showed significantly less intimal prolif-
eration. The SP treatment stimulated allograft reendothel-
ialization, as evidenced by strong intimal endothelial nitric
oxide synthase antibody and CD31 signals.
Gastrointestinal functions
Grac¸a et al. (2011) showed that a sulfated galactan isolated
from red algae Halymenia floresia has promising effects on
gastrointestinal (GI) motor functions mediated by voltage-
gated Ca2? channels. So, it is suggested that the SP can be
useful when gastrointestinal contraction is necessary during
motility-related disorders. Inflammatory bowel disease
caused by enteric pathogens is a severe form of gastric
disease characterized by excess production of proinflam-
matory cytokine IL-6. Fucoidan derived from brown algae
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C. okamuranus Tokida imparts LPS tolerance and prevents
the expression of IL-6 mRNA as evidenced by in vitro and
in vivo tests (Matsumoto et al. 2004).
In regenerative and nano medicine
Sezer et al. (2008) prepared a fucoidan–chitosan hydrogel
by swelling the polymers in acidic solution and investi-
gated its dermal burn treatment efficiency. Dermal burns
were inflicted on male New Zealand white rabbits and the
prepared hydrogel was applied on the wounds. Histopa-
thological evaluation of the biopsy samples was done at
intervals. No edema was seen in tested groups after 3-day
treatment and fibroplasia and scar were fixed after 7-day
treatment. The best regeneration on dermal papillary for-
mation and the fastest closure of the wounds were
observed in fucoidan–chitosan hydrogels after 14-day
treatment. Murakami et al. (2010) developed a hydrogel
sheet by blending alginate, chitosan and fucoidan, for
rapid wound healing. The hydrogel absorbed Dulbecco’s
minimal essential medium (DMEM) and fluid absorption
became constant within 18 h. On application, this hydro-
gel is expected to act as tissue adhesive and heal the
wound in a moist milieu. Histological examination
showed the advanced granulation tissue and capillary
formation in the healing-impaired wounds treated with the
hydrogel on day 7. Nakamura et al. (2008) reported that a
chitosan/fucoidan complex-hydrogel enhanced the half
life of fibroblast growth factor (FGF-2) by shielding it
against denaturants as heat and proteolysis. Subcutaneous
injection of the FGF-2-containing complex-hydrogel into
the back of mice showed controlled release of bioactive
protein. Slow diffusion of the growth factor induced
neovascularization and fibrous tissue formation near the
site of injection after 1 week. The complex-hydrogel was
biodegraded after 4 weeks after supplying adequate
amount of the angiogenic agents for protection of the
ischemic heart. Fukuta and Nakamura (2008) reported that
fucoidan and its oligosaccharides have the ability to
stimulate production of hepatocyte growth factor (HGF)
by induction during translation. So, it is believed that
fucoidan may protect tissues and organs by mechanisms
involving HGF.
Toskas et al. (2011) evaluated the nanofiber ability of
an ulvan-rich extract from the alga Ulva rigida. Ulvan-
based uniform, crystalline nanofibers of diameter 84 nm
were produced by blending them with poly(vinyl alco-
hol) (PVA). The interesting biological and physico-
chemical properties of the nanofibers can lead to new
biomedical applications such as drug release systems.
Taken together, these findings indicate that the SP can
revolutionize regenerative and nanomedicine, if exploited
properly.
Bottlenecks encountered
Extraction yield differs with respect to species, period and
season of seaweed harvest (Robic et al. 2009). The SP are
extracted from the seaweed biomass by many methods
which influence their amount and chemical composition.
The fucans of brown algae are highly complex and heter-
ogeneous in structure, rendering their study difficult.
Fonseca et al. (2008) compared the galactans from two
species of red algae having same structure and size but
slight variation in sulfation. Due to the variation in sulfate
content, the two SP differed in their anticoagulant and
venous antithrombotic activities. From the results it was
concluded that slight differences in the proportions of
sulfated residues in the galactan chain may be critical for
the interaction between proteases, inhibitors and activators
of the coagulation system. Also, the variations pose chal-
lenges in developing therapeutics. Furthermore, the high
molecular weights of SPs pose issue in bio-availability
(Jiao et al. 2011).
Structure–function correlation of SP
It is important to understand the biochemical and molecular
mechanism of therapeutic actions of SP, in order to
develop effective drugs. The monomeric constituents,
molecular size, sulfation site, specific structural motif,
degree of branching determination are vital for reproduc-
ibility of result. Pomin (2009) has reported that the anti-
coagulant action of SP lies in its ability to inhibit plasma
proteases via allosteric changes. The stereospecificities of
the carbohydrate–protein complexes hinge on the number
of residues in the repeating units, sulfation pattern, ano-
meric configuration, glycosidic linkage position and
molecular mass. Also, the heterogeneities, such as acety-
lation, methylation and pyruvilation contribute in eliciting
variations in functionality (Bilan et al. 2007). A single
structural change has been traced to result considerable
qualitative difference in results. Pomin and Mourao (2008)
reported that preparation of oligosaccharides with well-
defined chemical structures from sulfated fucan helps in the
studies of carbohydrate–protein interaction. Fonseca et al.
(2008) reported that algal sulfated galactans have a
procoagulant effect along with the serpin-dependent anti-
coagulant activity. The procoagulant effect depends on the
sulfation pattern of the SP. Slight differences in the pro-
portions and/or distribution of sulfated residues along the
galactan chain is critical for the interaction between pro-
teases, inhibitors, and activators of the coagulation system,
resulting in a distinct pattern in anti- and procoagulant
activities. Identification of structural attributes of SP vital
for their biological activities has been limited by their
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heterogeneous structures. Alasalvar et al. (2010) reported
the strong correlation between structure of SP and their
antioxidant potency. The monomeric constitution, degree
of sulfation and their position, type of glycosidic linkage
were held chief determining factors for variation in activ-
ity. High sulfate content and low molecular size were
studied to exert stronger radical scavenging activities.
Frenette and Weiss (2000) determined that sulfation is
critical for efficacy of fucoidan in hematopoietic progenitor
activity. The desulfated fucoidan failed to promote angio-
genesis in vitro or to induce immature CD34? cell mobi-
lization in vivo. Fucoidan inhibits the human complement
system mediated through interactions with certain proteins
belonging to the classical pathway, particularly the protein
C4. NMR spectra showed that the branched fucoidan oli-
gosaccharides display a better anticomplementary activity
compared to linear structures. Spectroscopy and molecular
modeling of fucoidan oligosaccharides indicated that the
presence of side chains reduces the flexibility of the back-
bone, mimicking a conformation recognized by the protein
C4 (Clement et al. 2010). Leiro et al. (2007) observed that
immunostimulatory activity of ulvan-like SP extracted from
U. rigida was decreased significantly after desulfation of the
SP, suggesting the importance of the functional group in
eliciting immune response. To tackle the problem of heter-
ogeneity of algal SP, a new approach has been established.
The information obtained from studies of invertebrate SP
that have a regular structure can be used to deduce the
functionally of algal SP (Jiao et al. 2011).
Maximization of the extraction and improvement
in bioavailability
Aqueous (Ghosh et al. 2009) and acetone extraction
(Marques et al. 2012) are the most prevalent techniques in
SP production from seaweeds. Due to the variations in
active growth parameters and extraction conditions, every
new SP purified is a unique compound with signature
structural features, promising a potential new drug.
Rodriguez-Jasso et al. (2011) extracted fucoidan from
brown seaweed F. vesiculosus by microwave-assisted
extraction. Extraction at 120 psi, 1 min, using 1 g/25 ml
water proved optimum condition for maximum fucoidan
recovery. It was concluded that pressure, extraction time
and alga/water ratio affected the SP yield (Rodriguez-Jasso
et al. 2011). Supercritical CO2 extraction, ultrasonic-aid
extraction and membrane separation technology may be
applied to harvest SP from the seaweeds. Short extraction
times, and non-corrosive solvents, cost effective an envi-
ronmentally benign technique are required for maximum
yield. Acid hydrolysis of high molecular weight fucans into
low molecular weight compounds facilitates their structural
investigation. Further, the low molecular weight fucoidans
can be obtained by fucoidanase (E.C.3.2.1.44) treatment.
This enzyme sourced from hepatopancreas of invertebrates,
marine bacteria and fungi has an added advantage of
hydrolyzing the SP without messing with its side substitute
groups (Qianqian et al. 2011). Endolytic enzymes, such as
ulvan lyases isolated from the flavobacteria Persicivirga
ulvanivorans cleave the glycosidic bond between the sul-
fated rhamnose and a glucuronic or iduronic acid in the
ulvans (Collen et al. 2011). Alkali modifications of car-
rageenans are suggested for improved application potential
(Campo et al. 2009). Success of commercial reproducibil-
ity of highly diverse fucoidan lies in proper characteriza-
tion with the help of powerful analytical tools (Fitton
2011).
Conclusion
The research on SP from seaweeds and their wide bio-
logical spectrum have skyrocketed in recent years. Their
clinical evaluation for possible noble therapeutics devel-
opment is catching momentum like never before. For above
goals to materialize, the underlying molecular mechanisms
need to be understood precisely and elucidated clearly. The
relation between structure and function should be unrav-
eled by intensive studies. This up-to-date review on this
emerging technique is expected to contribute significantly
in supplementing background knowledge, kindling interest
for future explorations. Further purification steps and
investigation on structural features as well as in vivo
experiments are needed to test the viability of their use as
therapeutic agents. The SP with appreciably few side
effects and myriad benefits could potentially be exploited
for complementary medicine use and disease management.
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